Structural elements of kallistatin required for inhibition of angiogenesis.
about
The Potential Role of Kallistatin in the Development of Abdominal Aortic AneurysmBile acid-induced negative feedback regulation of the human ileal bile acid transporterProtection effect of kallistatin on carbon tetrachloride-induced liver fibrosis in rats via antioxidative stressChronically administered retinoic acid has trophic effects in the rat small intestine and promotes adaptation in a resection model of short bowel syndromeKruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression.Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6Compartmental modeling of whole-body vitamin A kinetics in unsupplemented and vitamin A-retinoic acid-supplemented neonatal rats.Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activationDepletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling.Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool.Nogo-B receptor is essential for angiogenesis in zebrafish via Akt pathwayNatural and synthetic inhibitors of kallikrein-related peptidases (KLKs).Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsisNogo-B protects mice against lipopolysaccharide-induced acute lung injuryKallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis.Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.Marine cyclotripeptide X-13 promotes angiogenesis in zebrafish and human endothelial cells via PI3K/Akt/eNOS signaling pathwaysAdvances in short bowel syndrome: an updated review.A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells.SERPINA4 is a novel independent prognostic indicator and a potential therapeutic target for colorectal cancer.Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.Kallistatin protects against bleomycin-induced idiopathic pulmonary fibrosis by inhibiting angiogenesis and inflammation.The vicious cycle of vitamin a deficiency: A review.Kallistatin suppresses cancer development by multi-factorial actions.Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression.Heparin enhances serpin inhibition of the cysteine protease cathepsin L.Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas.Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity.Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathwayProtective Role of Kallistatin in Vascular and Organ Injury.Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice.All-trans retinoic acid enhances differentiation and influences permeability of intestinal Caco-2 cells under serum-free conditions.Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation.Nutrition Deficiencies in Children With Intestinal Failure Receiving Chronic Parenteral Nutrition.Retinoid metabolism in the small intestine during development of liver cirrhosis.Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction.Dietary supplementation with orotate and uracil increases adaptive growth of jejunal mucosa after massive small bowel resection in rats.Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway.Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin.
P2860
Q26741231-A0B856DB-7C10-41BF-8155-64939CC627C7Q28270599-C19FF43B-1A2F-4C8F-A66D-6DF79BDACEFCQ28539856-F3637375-C8B6-404B-BFBB-C4D84C721228Q28568173-49D864B0-3CD4-4C6D-B7AA-09E4CA6C34B4Q33512668-472E8F8A-E27F-41BF-96A5-C9C0C137E9D2Q33939375-5F174BB2-C338-4C2A-BE14-9E604D6DA1E8Q33945119-81878954-0C50-4BFB-9037-D82EC53A8EE7Q34070667-750CFDFA-AE15-4414-96AB-0B62B41959B7Q34289034-5D60D6FB-111F-4CFC-B0A9-4C57867DA9E7Q34441092-D5186011-9807-430A-BE4D-E9F9EB1CFA7AQ34450513-BF1DCCFC-B44F-4ABC-AFB4-25DF5C310FDFQ34457491-7BEEC84F-B22E-4AB5-999B-8BC242BBA4BFQ35070827-90560609-451C-4269-8E54-AFCDAF3014A9Q35654838-A0C66A97-822B-4F2D-9AEE-1783AEFA686FQ35852315-CF596249-A5BD-4296-8AA7-AD454C884455Q35877298-774799FB-6990-41D3-B86A-38D3DD8330E5Q36029511-ED440C04-F01A-44BF-A0DB-BE90C8947151Q36096701-47391DCD-D3F1-40B6-8C57-7253C6F7686DQ36305460-866E4E17-E318-45AD-A4F4-51FAA20BCBBFQ36893507-32615FBA-E947-4B7A-9706-6BE27EAA98F8Q37215516-FF13717C-9A7A-4301-BADF-5AC75A387CE6Q37370247-1A593AA2-2A68-44DC-B4D3-F5A43DFCEAAAQ37732963-4806546B-92B8-4A26-B954-2D9F557CD62DQ38820788-68C53DAE-9E2E-41BE-9069-A5889B8C1818Q39252905-D410786F-F001-4EB2-8F33-58158EC587A0Q39458426-14A47539-5824-4953-B6F8-24BD98D21572Q39767236-42B0C337-D2BD-4DD6-BE57-013BE2F9435FQ40002803-968A25EB-DE1F-4955-BB3B-A7AF9FA6A1A8Q40142736-CD2F524C-3561-491D-BC95-BA608702C04BQ40988610-154DD5B9-27C0-4C37-902E-3693CAF49CD2Q42360588-8F3FE1AC-4C17-4F91-A945-024D9B817441Q43285632-666E6C39-6ED2-467D-8D20-297E5431DA45Q45194950-54A7937E-2153-40CD-80FF-AC7580314AF2Q45882701-DA332847-A213-4679-AC1A-37C5E226DA55Q46106509-B30B2B4A-B4F0-438B-9AF3-A8AA62D7D977Q46117664-3B181BDA-9B56-4A34-8BA4-F967F17F0B2CQ46397663-8307C2FD-0350-4302-99AF-87378B408BF5Q46656475-2B78C7BE-D40F-4E44-87D8-E6BD71EC2E7AQ48129770-8351378C-5B75-4796-A88C-EACCC7395E59Q49179977-BC8AEF9D-124C-4110-9D73-08327DA8F6B6
P2860
Structural elements of kallistatin required for inhibition of angiogenesis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Structural elements of kallistatin required for inhibition of angiogenesis.
@ast
Structural elements of kallistatin required for inhibition of angiogenesis.
@en
Structural elements of kallistatin required for inhibition of angiogenesis.
@nl
type
label
Structural elements of kallistatin required for inhibition of angiogenesis.
@ast
Structural elements of kallistatin required for inhibition of angiogenesis.
@en
Structural elements of kallistatin required for inhibition of angiogenesis.
@nl
prefLabel
Structural elements of kallistatin required for inhibition of angiogenesis.
@ast
Structural elements of kallistatin required for inhibition of angiogenesis.
@en
Structural elements of kallistatin required for inhibition of angiogenesis.
@nl
P2093
P2860
P356
P1476
Structural elements of kallistatin required for inhibition of angiogenesis.
@en
P2093
Julie Chao
Robert Q Miao
Vincent Chen
P2860
P304
P356
10.1152/AJPGI.00524.2002
P577
2003-06-01T00:00:00Z